Wikidata

(Q40486635)

English

Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models

scientific article

In more languages

Statements

title
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
author name string
Nehal S Parikh
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Mark A Currier
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Yonatan Y Mahller
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Lisa C Adams
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Betsy Di Pasquale
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Margaret H Collins
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
Timothy P Cripe
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
publication date
1 May 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017
page(s)
469-478
1 reference
stated in
Europe PubMed Central
PubMed ID
15570577
retrieved
20 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40486635&oldid=1898101892"